Učitavanje...
Carboplatin-etoposide combination chemotherapy in metastatic castration-resistant prostate cancer: A retrospective study
The combination of cisplatin or carboplatin and etoposide is the standard treatment for certain poorly differentiated neuroendocrine cancers, such as small-cell lung cancer. The aim of this study was to assess the efficacy and tolerability of the carboplatin-etoposide regimen in metastatic castratio...
Spremljeno u:
| Izdano u: | Mol Clin Oncol |
|---|---|
| Glavni autori: | , , , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2015
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4665308/ https://ncbi.nlm.nih.gov/pubmed/26807222 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2015.628 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|